Comments

DiaMedica Therapeutics Stock Price, Quotes and Forecasts

Q: What sector and industry does DiaMedica Therapeutics (DMAC) operate in?

DiaMedica Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.

DMACNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$4.20

0.133.19%

At close: -

$3.99

-0.21-5.00%

After Hours: May 16, 9:26 AM EDT

Q1 2025 Earnings were released on Tue May 13th, after the market close

The most recent conference call was at 8:00 AM, 3 days ago Click to view past webcast

DiaMedica Therapeutics (DMAC) Forecast

News Earnings DiaMedica Therapeutics (DMAC) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings

DiaMedica Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:DMAC | Benzinga

Explore DiaMedica Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for DMAC.

Open	$3.94
Close	$4.20
Volume / Avg.	100.77K / 96.14K
Day Range	$3.82 - $4.28
52 Wk Range	2.14 - 6.82
Market Cap	$170.99M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	54
Short Interest	2.29%
Days to Cover	6.46

Recent News

Why Ericsson Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

This Fastenal Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

Avi Kapoor

DiaMedica Raises $37.5M Via Equity Offering, Aiding Development Activities For DM199

DiaMedica Therapeutics Inc. (NASDAQ: DMAC) has entered into an agreement with accredited investors that have agreed to provide up to $37.5 million in gross proceeds through a

Nabaparna Bhattacharya

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$3.94
Close	$4.20
Volume / Avg.	100.77K / 96.14K
Day Range	$3.82 - $4.28
52 Wk Range	2.14 - 6.82
Market Cap	$170.99M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	54
Short Interest	2.29%
Days to Cover	6.46

About

Sector

Healthcare

Industry

N/A

DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is engaged in ...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy DiaMedica Therapeutics (DMAC) stock?

You can purchase shares of DiaMedica Therapeutics (NASDAQ:DMAC) through any online brokerage.

View our list of the best stock brokerages

Who are DiaMedica Therapeutics (DMAC) competitors?

There are no as such competitors for DiaMedica Therapeutics.

What is the forecast, or price target, for DiaMedica Therapeutics (DMAC) stock?

DiaMedica Therapeutics has a consensus price target of $8.00.

What is the current price for DiaMedica Therapeutics (DMAC)?

The stock price for DiaMedica Therapeutics (NASDAQ: DMAC) is $3.99 last updated May 16, 2025 at 9:26 AM EDT.

Does DiaMedica Therapeutics (DMAC) pay a dividend?

There are no upcoming dividends for DiaMedica Therapeutics.

When is DiaMedica Therapeutics (NASDAQ:DMAC) reporting earnings?

DiaMedica Therapeutics’s Q2 earnings are confirmed for Wednesday, August 6, 2025.

Is DiaMedica Therapeutics (DMAC) going to split?

There is no upcoming split for DiaMedica Therapeutics.

What sector and industry does DiaMedica Therapeutics (DMAC) operate in?

DiaMedica Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.